Percutaneous-perventricular device closure of ventricular septal defect: mid-term follow-up
Abstract Background This report presents updated data and mid-term follow-up information to a former study introducing the novel technique of percutaneous-perventricular device closure of doubly committed subarterial ventricular septal defect. Methods Thirty-eight patients were added to the former s...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2020-09-01
|
| Series: | BMC Surgery |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s12893-020-00854-0 |
| _version_ | 1819203291646525440 |
|---|---|
| author | Long Wang Lin Xie Weiqiang Ruan Tao Li Changping Gan Ke Lin |
| author_facet | Long Wang Lin Xie Weiqiang Ruan Tao Li Changping Gan Ke Lin |
| author_sort | Long Wang |
| collection | DOAJ |
| description | Abstract Background This report presents updated data and mid-term follow-up information to a former study introducing the novel technique of percutaneous-perventricular device closure of doubly committed subarterial ventricular septal defect. Methods Thirty-eight patients were added to the former series. There were 54 patients in total who had isolated doubly committed subarterial ventricular septal defects and underwent percutaneous-perventricular device closure. Closure outcomes and possible complications were measured in the hospital and during the 2.5-year follow-up. Results Surgery was successful in 53 patients (98.1%). There was no death, residual shunt, new valve regurgitation or arrhythmia either perioperatively or during the entire follow-up period. Only one patient developed pericardial effusion and tamponade in the former series. The mean hospital stay was 3.2 ± 0.6 days (range, 3.0 to 6.0 days), and only one unsuccessful case needed blood transfusion (1.9%). Conclusions The percutaneous-perventricular device closure of isolated doubly committed subarterial ventricular septal defects appeared to be safe. Close monitoring for bleeding is essential postoperatively, especially in younger patients. This technique is generally safe with acceptable mid-term follow-up. |
| first_indexed | 2024-12-23T04:17:35Z |
| format | Article |
| id | doaj.art-402c5cc7b7d4420bb39faffe93b604c9 |
| institution | Directory Open Access Journal |
| issn | 1471-2482 |
| language | English |
| last_indexed | 2024-12-23T04:17:35Z |
| publishDate | 2020-09-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Surgery |
| spelling | doaj.art-402c5cc7b7d4420bb39faffe93b604c92022-12-21T18:00:21ZengBMCBMC Surgery1471-24822020-09-012011510.1186/s12893-020-00854-0Percutaneous-perventricular device closure of ventricular septal defect: mid-term follow-upLong Wang0Lin Xie1Weiqiang Ruan2Tao Li3Changping Gan4Ke Lin5Department of Cardiovascular Surgery, West China Hospital, Sichuan UniversityDepartment of Cardiovascular Surgery, West China Hospital, Sichuan UniversityDepartment of Cardiovascular Surgery, West China Hospital, Sichuan UniversityDepartment of Cardiovascular Surgery, West China Hospital, Sichuan UniversityDepartment of Cardiovascular Surgery, West China Hospital, Sichuan UniversityDepartment of Cardiovascular Surgery, West China Hospital, Sichuan UniversityAbstract Background This report presents updated data and mid-term follow-up information to a former study introducing the novel technique of percutaneous-perventricular device closure of doubly committed subarterial ventricular septal defect. Methods Thirty-eight patients were added to the former series. There were 54 patients in total who had isolated doubly committed subarterial ventricular septal defects and underwent percutaneous-perventricular device closure. Closure outcomes and possible complications were measured in the hospital and during the 2.5-year follow-up. Results Surgery was successful in 53 patients (98.1%). There was no death, residual shunt, new valve regurgitation or arrhythmia either perioperatively or during the entire follow-up period. Only one patient developed pericardial effusion and tamponade in the former series. The mean hospital stay was 3.2 ± 0.6 days (range, 3.0 to 6.0 days), and only one unsuccessful case needed blood transfusion (1.9%). Conclusions The percutaneous-perventricular device closure of isolated doubly committed subarterial ventricular septal defects appeared to be safe. Close monitoring for bleeding is essential postoperatively, especially in younger patients. This technique is generally safe with acceptable mid-term follow-up.http://link.springer.com/article/10.1186/s12893-020-00854-0Ventricular septal defectMinimally invasive surgery |
| spellingShingle | Long Wang Lin Xie Weiqiang Ruan Tao Li Changping Gan Ke Lin Percutaneous-perventricular device closure of ventricular septal defect: mid-term follow-up BMC Surgery Ventricular septal defect Minimally invasive surgery |
| title | Percutaneous-perventricular device closure of ventricular septal defect: mid-term follow-up |
| title_full | Percutaneous-perventricular device closure of ventricular septal defect: mid-term follow-up |
| title_fullStr | Percutaneous-perventricular device closure of ventricular septal defect: mid-term follow-up |
| title_full_unstemmed | Percutaneous-perventricular device closure of ventricular septal defect: mid-term follow-up |
| title_short | Percutaneous-perventricular device closure of ventricular septal defect: mid-term follow-up |
| title_sort | percutaneous perventricular device closure of ventricular septal defect mid term follow up |
| topic | Ventricular septal defect Minimally invasive surgery |
| url | http://link.springer.com/article/10.1186/s12893-020-00854-0 |
| work_keys_str_mv | AT longwang percutaneousperventriculardeviceclosureofventricularseptaldefectmidtermfollowup AT linxie percutaneousperventriculardeviceclosureofventricularseptaldefectmidtermfollowup AT weiqiangruan percutaneousperventriculardeviceclosureofventricularseptaldefectmidtermfollowup AT taoli percutaneousperventriculardeviceclosureofventricularseptaldefectmidtermfollowup AT changpinggan percutaneousperventriculardeviceclosureofventricularseptaldefectmidtermfollowup AT kelin percutaneousperventriculardeviceclosureofventricularseptaldefectmidtermfollowup |